Pulmonary Arterial Hypertension Studies Need to Consider Sex-Based Differences
In studies of pulmonary arterial hypertension, to what extent does sex/gender affect baseline values for measures such as 6MWD, hemodynamics, and functional class?
Pulmonary Arterial Hypertension
Mortality and Thyroid-Stimulating Hormone in Pulmonary Arterial Hypertension
Is mortality from PAH linked to thyroid dysfunction? To explore this, researchers measured thyroid stimulating hormone levels in patients with PAH.
Nomogram Predicts OSA in Patients With Pulmonary Arterial Hypertension
A newly developed nomogram for predicting OSA in patients with PAH may facilitate early identification and treatment of OSA in these patients.
Is Conduction Disease More Prevalent in Idiopathic Pulmonary Hypertension?
How prevalent is disordered cardiac conduction in patients with IPAH, and how does the condition affect patient functioning and prognosis?
Long-Term Sotatercept Efficacy in Pulmonary Arterial Hypertension
An open-label extension study of the PULSAR trial evaluated sotatercept treatment of patients with pulmonary arterial hypertension over 12 to 18 months.
Socioeconomic Factors Linked to Treatment Delays in Veterans with PAH
Are delays in treatment for pulmonary arterial hypertension the cause of the poorer PAH outcomes seen among individuals in socially disadvantaged groups?
Long-Term Safety, Tolerability of Ralinepag in Pulmonary Arterial Hypertension
Findings of a long-term study on the safety and efficacy of ralinepag for pulmonary arterial hypertension are consistent with earlier clinical trial findings.
Does Midodrine Help Patients Tolerate Pulmonary Arterial Hypertension Therapy?
Can midodrine effectively stabilize blood pressure in patients with pulmonary arterial hypertension, thus enabling them to increase their PAH medication dosage?
Impaired Gas Exchange During Submaximal Exercise and Clinical Worsening in PAH
In patients with pulmonary arterial hypertension, is abnormal pulmonary gas exchange during submaximal exercise associated with greater risk of clinical worsening events?
Are Peripheral Arterial Dysfunction and Stiffness Associated With PAH?
How is PAH severity related to peripheral endothelial dysfunction and arterial stiffness, and how does PAH treatment affect these variables?
- Loading...
Loading...
Next post in ATS 2022 In-depth PAH
Loading... 
Loading...